KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Non-Current Assets (2016 - 2025)

Biogen (BIIB) has 17 years of Non-Current Assets data on record, last reported at $20.5 billion in Q4 2025.

  • For Q4 2025, Non-Current Assets fell 0.62% year-over-year to $20.5 billion; the TTM value through Dec 2025 reached $81.5 billion, changed 0.09%, while the annual FY2025 figure was $20.5 billion, 0.62% down from the prior year.
  • Non-Current Assets reached $20.5 billion in Q4 2025 per BIIB's latest filing, up from $20.3 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $21.5 billion in Q3 2024 and bottomed at $14.7 billion in Q2 2023.
  • Average Non-Current Assets over 5 years is $18.0 billion, with a median of $18.5 billion recorded in 2021.
  • Peak YoY movement for Non-Current Assets: dropped 11.26% in 2022, then skyrocketed 35.38% in 2023.
  • A 5-year view of Non-Current Assets shows it stood at $16.0 billion in 2021, then decreased by 7.85% to $14.8 billion in 2022, then surged by 35.38% to $20.0 billion in 2023, then increased by 3.04% to $20.6 billion in 2024, then dropped by 0.62% to $20.5 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Assets were $20.5 billion in Q4 2025, $20.3 billion in Q3 2025, and $20.4 billion in Q2 2025.